Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00956579 · ClinicalTrials.gov registry record
Sensory and Connectivity Abnormalities in Autism Spectrum Disorders
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 85
- Enrollment target
NCT00956579: Completed study, sponsored by Massachusetts General Hospital.
NCT00956579 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00956579 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 85 participants
- Enrollment target
Study Summary
Study the neural substrates of autism spectrum disorders using neuroimaging methods such as MEG/EEG/MRI.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2013-06 |
| Est. Completion | 2025-06 |
What the finished NCT00956579 record still lists
NCT00956579 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 85 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00956579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00956579 about?
NCT00956579 is a clinical study titled "Sensory and Connectivity Abnormalities in Autism Spectrum Disorders". Study the neural substrates of autism spectrum disorders using neuroimaging methods such as MEG/EEG/MRI.
What is the current status of trial NCT00956579?
This trial is currently completed. The enrollment target is 85 participants. The study started on 2013-06. Estimated completion is 2025-06.
Who is sponsoring clinical trial NCT00956579?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia